Moreover, we have previously provided evidence for the upregulation of MMP-21 in ESCC patients, which was correlated with advanced stages and tumor invasion depth[16]; thus, it facilitates the aggressive pattern of these lesions. This evidence concerns the gene MMP21 and esophageal squamous cell carcinoma.